Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
Stopped Study halted due to low recruitment, unrelated to safety or efficacy reasons
Conditions
- Regional Citrate Anticoagulation (RCA)
- Continuous Renal Replacement Therapy (CRRT)
- Acute Kidney Injury
Interventions
- DRUG: Prismocitrate 18
- OTHER: No Anticoagulation
Sponsor
Vantive Health LLC
Collaborators